Panax notoginseng-Derived Carbon Quantum Dots as a Novel Administration Strategy for Cerebral Ischemia–Reperfusion Injury Therapy
- 1Department of Neurology , Affiliated Hospital of Shandong University of Traditional Chinese Medicine , Jinan 250014, .
- 2Institute for Chinese Medicine and Brain Science , Shandong University of Traditional Chinese Medicine , Jinan 250355, .
- 3First College of Clinical Medicine , Shandong University of Traditional Chinese Medicine , Jinan 250355, .
Abstract
The present study aimed to synthesize Panax notoginseng-derived carbon quantum dots (PN-CDs) and explore their role in cerebral ischemia-reperfusion injury (CIRI). PN-CDs were synthesized by the hydrothermal method, and characterization and biocompatibility were assessed. Next, CIRI models were established using SH-SY5Y cells, primary neurons were treated with oxygen-glucose deprivation/reoxygenation (OGD/R), and rats were subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). After PN-CDs treatment, inflammation, apoptosis, and oxidative stress were detected in neuronal cells and rats using enzyme-linked immunosorbent assay, quantitative reverse transcription polymerase chain reaction, flow cytometry, Western blot, and 2',7'-dichlorodihydrofluorescein diacetate probe. Meanwhile, 2,3,5-triphenyltetrazolium chloride, terminal deoxynucleotidyl transferase dUTP nick end labeling, Nissl, and hematoxylin and eosin staining were employed to measure the pathological damage of rats. Additionally, CIRI rats were administered with PN-CDs, Panax notoginseng saponins (PNS), Panax notoginseng (PN), or edaravone to investigate whether PN-CDs had the best effect. The findings revealed that PN-CDs exhibited favorable biocompatibility and crossed the blood-brain barrier. In vitro, PN-CD treatment inhibited oxidative stress, apoptosis, and inflammation, as evidenced by the decrease of interleukin-1β (IL-1β), IL-6, Bax, C-caspase-3, tumor necrosis factor-α, malondialdehyde, and reactive oxygen species and the increase of superoxide dismutase, Bcl-2, and glutathione. In CIRI rats, PN-CDs improved pathological damage and suppressed inflammation, apoptosis, and oxidative stress. The therapeutic effect of PN-CDs on CIRI was distinctly better than that of PNS and PN, and comparable to that of the first-line drug edaravone. In short, PN-CDs, a novel and efficient administration strategy, alleviates CIRI by inhibiting apoptosis, oxidative stress, and inflammation.
Related
- Investigation of the Effects of Kahweol, Flurbiprofen and Co-Administration of Kahweol and Flurbiprofen on Vas Deferens, Testis and Sperm Against Ischemia-Reperfusion Injury Induced by Testicular Torsion and Detorsion in Rats
- Applications of Nano Drug Delivery Systems in The Diagnosis and Treatment of Cerebral Ischemia-reperfusion Injury
- Novel Triazole-Adenosine Conjugates as Mammalian Seryl-tRNA Synthetase Inhibitors to protect cells from Ischemia-Reperfusion Injury
- Phytochemical Transformations of Panax notoginseng Saponins During Thermal Processing and Their Potential Implications for Iron Homeostasis Through Hepcidin-Related Pathways
- Detection of Tiludronic Acid in Equine Hair and Its Segmental Analysis Following Administration
BibTeX
@article{cui2026panax,
title = {{Panax notoginseng-Derived Carbon Quantum Dots as a Novel Administration Strategy for Cerebral Ischemia–Reperfusion Injury Therapy}},
author = {Wen-Qiang Cui and Sheng Wei and Hai-Tao Li and Hong-Wei Zhi and Jin-Ping Zhang and Yu Wang and Zhen-Ling Liu and Feng-Xian Hu and Xiang-Qing Xu and Hong-Yun Wu},
journal = {Biomaterials research},
year = {2026},
month = oct,
doi = {10.34133/bmr.0440},
url = {https://europepmc.org/article/PMC/PMC13716990},
note = {CC BY},
}
RIS
TY - JOUR
TI - Panax notoginseng-Derived Carbon Quantum Dots as a Novel Administration Strategy for Cerebral Ischemia–Reperfusion Injury Therapy
AU - Wen-Qiang Cui
AU - Sheng Wei
AU - Hai-Tao Li
AU - Hong-Wei Zhi
AU - Jin-Ping Zhang
AU - Yu Wang
AU - Zhen-Ling Liu
AU - Feng-Xian Hu
AU - Xiang-Qing Xu
AU - Hong-Yun Wu
PY - 2026
DA - 2026/10/29
JO - Biomaterials research
DO - 10.34133/bmr.0440
UR - https://europepmc.org/article/PMC/PMC13716990
AB - The present study aimed to synthesize Panax notoginseng-derived carbon quantum dots (PN-CDs) and explore their role in cerebral ischemia-reperfusion injury (CIRI). PN-CDs were synthesized by the hydrothermal method, and characterization and biocompatibility were assessed. Next, CIRI models were established using SH-SY5Y cells, primary neurons were treated with oxygen-glucose deprivation/reoxygenation (OGD/R), and rats were subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). After PN-CDs treatment, inflammation, apoptosis, and oxidative stress were detected in neuronal cells and rats using enzyme-linked immunosorbent assay, quantitative reverse transcription polymerase chain reaction, flow cytometry, Western blot, and 2',7'-dichlorodihydrofluorescein diacetate probe. Meanwhile, 2,3,5-triphenyltetrazolium chloride, terminal deoxynucleotidyl transferase dUTP nick end labeling, Nissl, and hematoxylin and eosin staining were employed to measure the pathological damage of rats. Additionally, CIRI rats were administered with PN-CDs, Panax notoginseng saponins (PNS), Panax notoginseng (PN), or edaravone to investigate whether PN-CDs had the best effect. The findings revealed that PN-CDs exhibited favorable biocompatibility and crossed the blood-brain barrier. In vitro, PN-CD treatment inhibited oxidative stress, apoptosis, and inflammation, as evidenced by the decrease of interleukin-1β (IL-1β), IL-6, Bax, C-caspase-3, tumor necrosis factor-α, malondialdehyde, and reactive oxygen species and the increase of superoxide dismutase, Bcl-2, and glutathione. In CIRI rats, PN-CDs improved pathological damage and suppressed inflammation, apoptosis, and oxidative stress. The therapeutic effect of PN-CDs on CIRI was distinctly better than that of PNS and PN, and comparable to that of the first-line drug edaravone. In short, PN-CDs, a novel and efficient administration strategy, alleviates CIRI by inhibiting apoptosis, oxidative stress, and inflammation.
SN - 1226-4601
SN - 2055-7124
ER -